Strategic supply chain design: flexibility and scalability considerations for optimal facility design

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Strategic supply chain design: flexibility and scalability considerations for optimal facility design

Live30 webinars are thirty minute presentations designed to update you on the latest innovations, applications and data in a fast yet interactive format.

The development of individualized medicine, as part of Cell & Gene Therapy (C&GT) platforms, is one of the greatest promises of the biopharmaceutical industry. The pipeline of advanced therapies is expanding, with several cell and gene therapies now reaching the market. The services required to develop them are in more demand than ever.

With new developments in the market, and high demand comes complex challenges with scalability. This presentation will explore C&GT supply chains challenges and drill down to its impact on facility operations and sizing concerns. We will focus on autologous therapies while discussing commonalities and differences with allogeneic therapies'.

How to approach facility readiness to unforeseen and often long lasting supply chain issues
How to appropriately size the spaces and systems around uncertainty
How to include flexibility and phasing considerations in facility design

Niranjan Kulkarni PhD

Senior Director, Consulting Services at CRB

Niranjan is the senior director of CRB’s consulting group. He holds a doctorate and master’s degree in industrial and systems engineering from Binghamton University. He is also a certified Lean Six Sigma Master Black Belt. Niranjan has over 15 years of experience in business process and data modeling, operations and process simulations, process improvements, layout optimizations and supply chain management. He has worked with the pharmaceutical, biotech, food, chemical, semiconductor, electronics assembly and packaging, manufacturing and financial industries.

Grace Linton RA AIA LEED AP BD+C

Director, Process Architecture at CRB

Grace is the director of process architecture at CRB. She supports the advancement of CRB's process architectural preeminence, with a focus on cGMP regulatory expertise, integrated facility design, and innovative design solutions. Grace has delivered projects in North America, Europe and Asia, covering a wide range of facility types, including cell and gene therapy, monoclonal antibodies, vaccines, blood fractionation, active pharmaceutical ingredients, oral solid dosage, medical devices, fill finish, and oligonucleotides.